Expanded polytetrafluoroethylene (ePTFE) vascular graft loses its thrombogenicity six months after implantation

Thrombosis Research
H AriyoshiM Monden

Abstract

Although expanded polytetrafluoroethylene (ePTFE) has been believed to be an inert material for vascular prosthesis, it shows less tendency of graft maturation by means of endothelialization. The aim of this study is to evaluate long-term alteration in thrombogenicity of ePTFE grafts after implantation. Serial levels of thrombin-antithrombin III complex (TAT), D-dimer, C-reactive protein (CRP), and prothrombin time (PT) were examined in 77 patients following ePTFE Y-graft implantation for up to five years. TAT showed biphasic elevation after implantation; TAT increased from 16.4+/-8.6 ng/ml to 27.4+/-10.5 ng/ml at one day, decreased to 18.5+/-4.5 ng/ml at one week, and increased again to 25.3+/-8.5 ng/ml at two weeks. Elevated TAT gradually decreased after the second peak to reach a lower level than that before surgery after six months. There was no significant difference in TAT level after six months due to the difference in diagnosis or anti-thrombotic therapy. We suggest that ePTFE grafts lose their thrombogenicity six months after implantation, after which anti-thrombotic therapy might be unnecessary.

References

Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J H Griffin
Aug 1, 1990·Plastic and Reconstructive Surgery·P C Johnson
Jan 1, 1988·Microsurgery·L S Nichter, A Bindiger
Nov 1, 1974·Archives of Surgery·L R SauvageP B Mansfield
Sep 15, 1983·Thrombosis Research·D B RylattA J Webber
May 1, 1982·The Journal of Surgical Research·R A YeagerR Keys
Nov 1, 1994·European Journal of Vascular Surgery·J M BellónF Jurado

❮ Previous
Next ❯

Citations

Apr 18, 2002·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Francesco SerinoAngelo Fusco
Jan 24, 2006·American Journal of Veterinary Research·Augusta PelosiN Bari Olivier
Apr 26, 2016·Journal of the Mechanical Behavior of Biomedical Materials·Yu XieMartin W King
Dec 13, 2006·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Peter J Bray, Alan E Bray
Feb 7, 2012·Vascular and Endovascular Surgery·Mark TattertonShervanthi Homer-Vanniasinkam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.